Japan Nuclear Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-08-01 I 65 Pages I Mordor Intelligence
Japan Nuclear Imaging Market Analysis
The Japan nuclear imaging market size is valued at USD 431.71 million in 2025 and is projected to reach USD 678.91 million by 2030, reflecting a 9.50% CAGR over the forecast period. Japan's well-funded universal health-insurance system, rapid population aging, and deep installed base of SPECT and PET scanners make it the world's most densely equipped diagnostic-imaging environment. Government incentives that link green-transformation spending to domestic isotope production, combined with hospital demand for AI-enhanced workflow tools, fuel steady equipment upgrades. Strategic consolidation, highlighted by GE HealthCare's full acquisition of Nihon Medi-Physics, is reshaping supplier power and accelerating local radiopharmaceutical innovation. Simultaneously, breakthroughs in alpha-particle therapy isotopes and deep-learning reconstruction algorithms are opening precision-oncology revenue streams that offset reimbursement pressure on conventional SPECT cardiac studies.
Japan Nuclear Imaging Market Trends and Insights
Rising Prevalence of Cardiovascular Diseases in Aging Population
Japan now counts more than 36 million residents aged 65 years or older, driving persistent demand for nuclear cardiology examinations that evaluate myocardial perfusion with technetium-99m agents. Hospitals are prioritizing high-sensitivity SPECT/CT upgrades to identify sub-clinical ischemia in asymptomatic seniors, a shift aligned with the Japan Radiological Society database that houses roughly 500 million de-identified images for AI training. Deep-learning reconstruction tools shorten acquisition times, lowering patient dose while preserving resolution, which improves throughput in congested urban facilities. Government policy encouraging value-based radiology further cements functional imaging as a standard work-up ahead of costly interventional procedures. The demographic effect therefore establishes a long-run volume floor for SPECT cardiac services despite competitive CT angiography technologies.
Expanding Insurance Coverage for Advanced Imaging
In April 2025, the Ministry of Health, Labour and Welfare broadened reimbursement for florbetapir-18F amyloid PET from diagnostic use to post-treatment monitoring of Alzheimer's therapy, cutting out-of-pocket costs and incentivizing facilities to install additional PET capacity. Similar coverage shifts are under review for PSMA-targeted tracers and theranostic agents, signaling a reimbursement pathway that links early detection to long-term cost containment. Rural prefectures benefit disproportionately because expanded coverage offsets travel expenses to metropolitan hospitals. Insurers also tie higher scan fees to adherence with AI-enabled dose-reduction protocols, encouraging adoption of advanced reconstruction software. As a result, payer policy increasingly guides purchasing decisions toward hybrid PET/MRI systems and AI-ready SPECT cameras.
Chronic Shortage of Mo-99 Global Supply Chain Disruptions
More than 85% of Japanese nuclear-medicine scans rely on technetium-99m, yet the isotope's parent Mo-99 is sourced mainly from aging foreign reactors that face unplanned outages. Import delays force hospitals to reschedule procedures and divert demand to CT or MRI, cutting SPECT utilization. Research cyclotrons have validated proton bombardment of natural molybdenum to make carrier-free technetium-99m, but scaling remains capital intensive. The interim risk drives bulk-purchasing alliances among major hospital chains and supports government interest in domestic isotope plants.
Other drivers and restraints analyzed in the detailed report include:
Government Funding for Theranostic Isotope Production Capabilities / Integration of AI-Based Reconstruction Algorithms Improving Image Quality / Stringent Regulatory Hurdles for Cyclotron Installation Licenses /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Equipment accounted for 62.34% of Japan nuclear imaging market share in 2024, underscoring the modality's entrenched role in routine cardiology and bone procedures. The segment's installed base benefits from comparatively low capital cost, abundant technologist expertise, and versatile isotope chemistry. Modern cadmium-zinc-telluride detectors lift energy resolution and shorten scan times, features that preserve SPECT relevance against PET challengers. Vendors bundle AI-enabled dose-optimization software to align with insurer dose-ceiling rules, reinforcing replacement sales cycles.
Radioisotopes though representing a small fraction of equipment units, is projected to post a 9.84% CAGR through 2030, the fastest in the modality mix. Clinical uptake accelerates in neurology and oncology centers where simultaneous metabolic and soft-tissue imaging improves lesion characterization. Shimadzu's FDA-cleared BresTome time-of-flight PET device marks Japan's innovation push into organ-specific imaging. On the radioisotope side, technetium-99m retains volume leadership, yet fluorine-18 tracers grow briskly as cyclotron capacity expands. Emerging alpha emitters such as astatine-211 promise differentiated therapeutics, positioning equipment vendors to cross-sell shielded hot-cells and theranostic workflow software. Consequently, the Japan nuclear imaging market sees a dual track: high-volume SPECT installations in regional centers and premium PET/MRI suites in tertiary hospitals.
The Japan Nuclear Imaging Market Report is Segmented by Product (Equipment: PET/CT Scanners, SPECT/CT Scanners, PET/MRI Scanners; Radioisotopes: SPECT and PET Radioisotopes), Application (Cardiology, Neurology, Thyroid, Oncology, Other Applications), and End User (Hospitals, Diagnostic Imaging Centres, Academic & Research Institutes). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
GEHealthcare / Siemens Healthineers / Canon / Nihon Medi-Physics Co., Ltd. / Fujifilm Healthcare Corporation / Shimadzu / Hitachi, Ltd. (Healthcare) / Koninklijke Philips / IBA (Ion Beam Applications SA) / Bracco Imaging S.p.A. / Cardinal Health / Eckert & Ziegler AG /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising prevalence of cardiovascular diseases in ageing population
4.2.2 Expanding insurance coverage for advanced imaging in Japan
4.2.3 Government funding for theranostic isotope production capabilities
4.2.4 Integration of AI-based reconstruction algorithms improving image quality
4.2.5 Surging demand for precision oncology companion diagnostics
4.2.6 Rapid adoption of out-patient imaging centers
4.3 Market Restraints
4.3.1 Chronic shortage of Mo-99 global supply chain disruptions
4.3.2 Stringent regulatory hurdles for cyclotron installation licenses
4.3.3 Competition from rapid CT/MRI advances reducing SPECT reimbursements
4.3.4 High capital expenditure limiting adoption in rural prefectures
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Buyers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Product (Value)
5.1.1 Equipment
5.1.1.1 PET/CT Scanners
5.1.1.2 SPECT/CT Scanners
5.1.1.3 PET/MRI Scanners
5.1.2 Radioisotopes
5.1.2.1 SPECT Radioisotopes
5.1.2.1.1 Technetium-99m (Tc-99m)
5.1.2.1.2 Thallium-201 (Tl-201)
5.1.2.1.3 Gallium-67 (Ga-67)
5.1.2.1.4 Iodine-123 (I-123)
5.1.2.1.5 Other SPECT Isotopes
5.1.2.2 PET Radioisotopes
5.1.2.2.1 Fluorine-18 (F-18)
5.1.2.2.2 Rubidium-82 (Rb-82)
5.1.2.2.3 Other PET Isotopes
5.2 By Application (Value)
5.2.1 Cardiology
5.2.2 Neurology
5.2.3 Thyroid
5.2.4 Oncology
5.2.5 Other Applications
5.3 By End User (Value)
5.3.1 Hospitals
5.3.2 Diagnostic Imaging Centres
5.3.3 Academic & Research Institutes
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 GE HealthCare
6.3.2 Siemens Healthineers
6.3.3 Canon Medical Systems Corporation
6.3.4 Nihon Medi-Physics Co., Ltd.
6.3.5 Fujifilm Healthcare Corporation
6.3.6 Shimadzu Corporation
6.3.7 Hitachi, Ltd. (Healthcare)
6.3.8 Koninklijke Philips N.V.
6.3.9 IBA (Ion Beam Applications SA)
6.3.10 Bracco Imaging S.p.A.
6.3.11 Cardinal Health, Inc.
6.3.12 Eckert & Ziegler AG
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.